Monthly Archives: July 2022

Action on Monkeypox Accelerates in US as Outbreak Expands

Two of the hardest-hit U.S. regions have raised the alert level over the monkeypox outbreak.San Francisco declared a public health emergency Thursday. The city accounts for 281 of California’s nearly 800 cases. The declaration gives health officials ac…

Syinix Launches World First Machine that can cook Africa Staple Food: Banku, FUFU etc.

ACCRA, Ghana, July 29, 2022 /PRNewswire/ — According to the study, 83% of African eat a variety of Swallow foods (such as Banku, fufu,etc.) as their staple food. For most of African, however, making swallow food is a difficult process, as users have to stir the food throughout, and the whole process is time-consuming as […]

UN Weekly Roundup: July 17-29, 2022

Anti-UN protests turn deadly in DRCThe acting head of the United Nations mission in eastern Congo said Wednesday that they would carry out a joint investigation with national police into the shooting deaths of three peacekeepers and a dozen Congolese c…

Top US Diplomat Travels to Asia, Africa as Global Powers Fight for Influence

U.S. Secretary of State Antony Blinken travels to East Asia and Africa next week seeking to counter the influence of Russia and China in a fight for global influence.Blinken begins his travels Tuesday on a tour that will take him to Cambodia, the Phili…

Report: Facebook Approved Hate Speech Calling for Ethnic Violence in Kenya

Kenyan authorities have called on Facebook to do more to rid the platform of hate speech ahead of the August 9 general election. Rights group Global Witness said the social media company approved hate speech advertisements promoting ethnic violence.Res…

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

DURHAM, N.C., July 28, 2022 (GLOBE NEWSWIRE) — Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November […]